Characterization and Evaluation of CD24 and NPY as Biomarkers for Metastatic Castration-Resistant Prostate Cancer

<b>Background/Objectives</b>: Prostate cancer is the most diagnosed and third most deadly cancer among men in Europe. Metastatic castration-resistant prostate cancer (mCRPC) is incurable and resistant to standard androgen ablation therapy. More biomarkers are needed to select patients for novel pers...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής

Κύριοι συγγραφείς:	Peter R. McHenry, Najla Fakhruddin, Kevin Homer, Rui M. Gil da Costa, Lawrence D. True, Colm Morrissey
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	MDPI AG 2026-02-01
Σειρά:	Diagnostics
Θέματα:	prostate cancer CRPC metastasis biomarker IHC CD24
Διαθέσιμο Online:	https://www.mdpi.com/2075-4418/16/5/657
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!